Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects
about
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.P2Y12 inhibitors in cardiovascular disease: focus on prasugrel.Prasugrel for the treatment of patients with acute coronary syndrome.P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.Prasugrel: a critical comparison with clopidogrel.What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.Genotypic and phenotypic assessment of platelet function and response to P2Y12 antagonists.TRITON and beyond: new insights into the profile of prasugrel.Importance of potent P2Y(12) receptor blockade in acute myocardial infarction: focus on prasugrel.Antiplatelet testing in neurointervention: we cannot ignore the signs.A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrel.Prasugrel hydrochloride for the treatment of acute coronary syndrome patients.The Rationale for and Clinical Pharmacology of Prasugrel 5 mg.Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study.Platelet Aggregation Inhibitory Effects and Pharmacokinetics of Prasugrel Used in Combination With Aspirin in Healthy Japanese SubjectsPharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitor.Inhibition of platelet aggregation with prasugrel and clopidogrel: an integrated analysis in 846 subjects.Efficacy and safety of prasugrel compared with clopidogrel in patients with acute coronary syndromes: results of TRITON-TIMI 38 trials.Prasugrel (Effient), an Adenosine Diphosphate Receptor Antagonist for the Treatment Of Acute Coronary Syndrome.Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysis.
P2860
Q36649213-59703F24-FA35-4E1D-8B3C-819A9743B0A3Q37339517-798F56D7-EC1C-4B68-8ED0-1A9E390DDF4EQ37479088-E9D6E4EA-6C5A-42CE-A291-29F6FF90E677Q37562606-966EC3BB-6B70-43FA-AC91-99434C14F150Q37641320-0B2ED385-4966-4F19-B615-957599B13A2EQ37704842-DB4D0982-75B6-4647-AA01-177DF004EA65Q37907918-9B6D3DDB-3A1A-4332-A11B-6541D9D0F9B0Q37925009-F8F6B853-02EC-4B4B-9297-E1BAA9659293Q38025446-050497AE-AD3D-49C4-8F98-BFAE93E4523FQ38114045-B9F0B747-6B70-4DD5-9311-AC0E74E715B8Q38475429-5382120F-809A-4F2B-91BA-E57EA8E0767FQ38972064-C41CDBC5-B543-47BA-96FF-BB8B2461B5BBQ39010701-8E7ECFF4-E9CD-47E3-97AE-37AEE6957C09Q41023511-B838B140-4EC5-4EA0-8841-A2B695FC7569Q41052640-32385141-459A-4224-9299-E6E9A5FB4711Q43288118-46F59BD3-74FB-467F-8DFF-F514C7BF0476Q45918033-2F9598BC-8C77-4EAE-8995-17E03BA4DEFDQ46184936-FF67B774-2515-4E6E-AA8D-77AB6A77EBABQ50285612-3C8B14DE-32D7-4E2F-AAD0-D542A7F413B1Q51905748-22499C08-FECF-4CDD-BDE6-A92BEAAF4B46
P2860
Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Dose-dependent inhibition of h ...... th aspirin in healthy subjects
@ast
Dose-dependent inhibition of h ...... th aspirin in healthy subjects
@en
Dose-dependent inhibition of h ...... th aspirin in healthy subjects
@nl
type
label
Dose-dependent inhibition of h ...... th aspirin in healthy subjects
@ast
Dose-dependent inhibition of h ...... th aspirin in healthy subjects
@en
Dose-dependent inhibition of h ...... th aspirin in healthy subjects
@nl
prefLabel
Dose-dependent inhibition of h ...... th aspirin in healthy subjects
@ast
Dose-dependent inhibition of h ...... th aspirin in healthy subjects
@en
Dose-dependent inhibition of h ...... th aspirin in healthy subjects
@nl
P2093
P1476
Dose-dependent inhibition of h ...... th aspirin in healthy subjects
@en
P2093
Christopher D Payne
D Richard Lachno
Govinda J Weerakkody
Hideo Naganuma
John T Brandt
Joseph A Jakubowski
Kenneth J Winters
Nagy A Farid
P304
P356
10.1097/FJC.0B013E318031301B
P407
P577
2007-03-01T00:00:00Z